History
HAEAMBIO Co., Ltd. has been relentlessly challenging itself to develop technologies that enable the fundamental treatment of diseases,
creating a future where healthy living is possible for everyone, everywhere in the world.
2024
- May 2024
- Technology Transfer Agreement
: Licensed-in the patent for compositions for the prevention and treatment of heart valve disease from the Catholic University Industry-Academic Cooperation Foundation
- February 2024
- Second Investment Agreement with Aju Pharm Co., Ltd.
2023
- March 2023
- MOU for Research Collaboration with MarkHerz Inc.
2021
- January 2021
- First Investment Agreement with Aju Pharm Co., Ltd.
2020
- September 2020
- Establishment of HAEAMBIO Co., Ltd.
:Faculty Startup from the Catholic University Industry-Academic Cooperation Foundation